Melanka Hoch
Associate Director at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Melanka Hoch’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Associate Director at Novo Nordisk in August 2025 - Present
Senior Project Manager - Novo Nordisk Consulting at Novo Nordisk in September 2024 - August 2025
Project Manager - Novo Nordisk Consulting at Novo Nordisk in September 2023 - September 2024
Senior Project Associate - Novo Nordisk Consulting at Novo Nordisk in August 2022 - August 2023
Inhouse Consulting Graduate - Global Graduate Program at Merck Group in June 2020 - May 2022
Working Student - Research at Fraunhofer Institute for Systems and Innovation Research ISI in November 2019 - March 2020
Working Student - Global Delivery Management Nutrition & Health (EN/LD) at BASF in February 2019 - June 2019
Working Student - Project Management at sovanta AG in March 2018 - July 2018
Intern - Inhouse Consulting Logistics at Robert Bosch GmbH in May 2016 - October 2016
Academic Tutor - Mathematics and Statistics Division at FH Aachen University of Applied Sciences in April 2014 - January 2015
Working Student - Marketing at EUtech Scientific Engineering GmbH in September 2013 - February 2014
University of Mannheim, July 2026
Smith School of Business at Queen's University, July 2026
Rennes School of Business, B. Sc., July 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Melanka Hoch email address?
Email Melanka Hoch at [email protected] and [email protected]. This email is the most updated Melanka Hoch's email found in 2026.
How to contact Melanka Hoch?
To contact Melanka Hoch send an email to [email protected] or [email protected]. (updated on November 28, 2025)
What company does Melanka Hoch work for?
Melanka Hoch works for Novo Nordisk.
What is Melanka Hoch's role at Novo Nordisk?
Melanka Hoch is Associate Director
What industry does Melanka Hoch work in?
Melanka Hoch works in the Pharmaceuticals industry.
